Systematic in vitro specificity profiling reveals nicking defects in natural and engineered CRISPR–Cas9 variants

Thumbnail Image
Date
2021-03-21
Authors
Suresh, Shravanti
Seetharam, Arun
Severin, Andrew
Sashital, Dipali
Major Professor
Advisor
Committee Member
Journal Title
Journal ISSN
Volume Title
Publisher
Authors
Person
Seetharam, Arun
Research Scientist IV
Person
Severin, Andrew
Manager Research
Research Projects
Organizational Units
Organizational Unit
Office of Biotechnology
The Office of Biotechnology facilitates and advances programs in research, education, and outreach that contribute to the goals of Iowa State University’s Strategic Plan in the area of biotechnology. The Office oversees the biotechnology programs developed by the university’s Biotechnology Council and the Office of the Vice President for Research. The Office of Biotechnology works with the university’s biotechnology faculty and administrators to ensure effectiveness in research, education, and technology transfer related to the application of molecular biology to the development of useful products and processes.
Organizational Unit
Biochemistry, Biophysics and Molecular Biology

The Department of Biochemistry, Biophysics, and Molecular Biology was founded to give students an understanding of life principles through the understanding of chemical and physical principles. Among these principles are frontiers of biotechnology such as metabolic networking, the structure of hormones and proteins, genomics, and the like.

History
The Department of Biochemistry and Biophysics was founded in 1959, and was administered by the College of Sciences and Humanities (later, College of Liberal Arts & Sciences). In 1979 it became co-administered by the Department of Agriculture (later, College of Agriculture and Life Sciences). In 1998 its name changed to the Department of Biochemistry, Biophysics, and Molecular Biology.

Dates of Existence
1959–present

Historical Names

  • Department of Biochemistry and Biophysics (1959–1998)

Related Units

Organizational Unit
Genome Informatics Facility
The Genome Informatics Facility serves as a centralized resource of expertise on the application of emerging sequencing technologies and open source software as applied to biological systems. Its mission is to integrate this knowledge into pipelines that are easy to understand and use by faculty, staff and students to enable the transformation of ‘big data’ into data that dramatically accelerates our understanding of biology and evolutionary processes.
Journal Issue
Is Version Of
Versions
Series
Department
Office of BiotechnologyBiochemistry, Biophysics and Molecular BiologyGenome Informatics FacilityMolecular, Cellular and Developmental Biology
Abstract

Cas9 is an RNA-guided endonuclease in the bacterial CRISPR–Cas immune system and a popular tool for genome editing. The commonly used Streptococcus pyogenes Cas9 (SpCas9) is relatively non-specific and prone to off-target genome editing. Other Cas9 orthologs and engineered variants of SpCas9 have been reported to be more specific. However, previous studies have focused on specificity of double-strand break (DSB) or indel formation, potentially overlooking alternative cleavage activities of these Cas9 variants. In this study, we employed in vitro cleavage assays of target libraries coupled with high-throughput sequencing to systematically compare cleavage activities and specificities of two natural Cas9 variants (SpCas9 and Staphylococcus aureus Cas9) and three engineered SpCas9 variants (SpCas9 HF1, HypaCas9 and HiFi Cas9). We observed that all Cas9s tested could cleave target sequences with up to five mismatches. However, the rate of cleavage of both on-target and off-target sequences varied based on target sequence and Cas9 variant. In addition, SaCas9 and engineered SpCas9 variants nick targets with multiple mismatches but have a defect in generating a DSB, while SpCas9 creates DSBs at these targets. Overall, these differences in cleavage rates and DSB formation may contribute to varied specificities observed in genome editing studies.

Comments

This article is published as Murugan, Karthik, Shravanti K. Suresh, Arun S. Seetharam, Andrew J. Severin, and Dipali G. Sashital. "Systematic in vitro specificity profiling reveals nicking defects in natural and engineered CRISPR–Cas9 variants." Nucleic Acids Research (2021). doi: 10.1093/nar/gkab163.

Description
Keywords
Citation
DOI
Copyright
Fri Jan 01 00:00:00 UTC 2021
Collections